PPII Coenzyme A Inc (CE)

Pro Pointer, Inc. (PINKSHEETS: PPII), through its wholly owned subsidiary, Coenzyme-A Technologies, Inc., today announced the introduction of its Clear Skin Image™ product to the rapidly growing nutricosmetic market. Nutricosmetics, or "beauty from within" products, are taken orally to improve health and beauty and is a rapidly growing category that is about to hit the major world markets. Most of the activity to date has taken place in Europe and Japan. In the United States the market is in its infancy because of American consumers' low awareness of the beauty benefits of oral supplementation of antioxidants and other phytonutrients. In a 2007 survey conducted by Kline & Company, an international leader in industry-specific market analysis, the global nutricosmetics market, which also takes into account the Cosmeceutical market, was valued at $1.5 billion -- a figure that is expected to grow to $2.5 billion by 2012.

Coenzyme-A Technologies, Inc. is incorporating the latest technological advancements in the nutricosmetics market by creating a uniquely formulated skin care product that works internally to treat problem skin caused by hormonal imbalances and metabolic deficiencies. Clear Skin Image™ targets the primary causes of acne-prone skin for all age groups. Environmental factors and chaotic lifestyles with everyday responsibilities place more demands on the body leading to overproduction of sebaceous oil by the oil glands resulting in acne. Clear Skin Image™ helps reduce pore size producing a smoother, softer looking complexion and vibrant skin. Clear Skin Image™ is clinically proven to be a safe and effective treatment to help eliminate acne.

Based on the successfully test-marketed premium pricing of the Clear Skin Image product, and upon a properly positioned advertising and marketing campaign, the immediate projected annual sales could very well exceed the 2.5 million dollar mark thus adding yet another effective sales category to this company's proprietary line of product developments.

ABOUT COENZYME-A TECHNOLOGIES, INC. -- Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website -- www.coenzyme-a.com.

FORWARD-LOOKING STATEMENTS The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contact Information: Pro-Pointer, Inc. 458 Coral Sea St. Henderson, NV 89074 Ph-702-458-4111 Cell-702-591-7440